HK1018204A1 - A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy - Google Patents

A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy

Info

Publication number
HK1018204A1
HK1018204A1 HK99103182A HK99103182A HK1018204A1 HK 1018204 A1 HK1018204 A1 HK 1018204A1 HK 99103182 A HK99103182 A HK 99103182A HK 99103182 A HK99103182 A HK 99103182A HK 1018204 A1 HK1018204 A1 HK 1018204A1
Authority
HK
Hong Kong
Prior art keywords
selegiline
medicament
manufacture
preventing
peripheral neuropathy
Prior art date
Application number
HK99103182A
Other languages
English (en)
Inventor
George Bobotas
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of HK1018204A1 publication Critical patent/HK1018204A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK99103182A 1996-03-15 1999-07-23 A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy HK1018204A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352096P 1996-03-15 1996-03-15
PCT/US1997/004584 WO1997033572A1 (en) 1996-03-15 1997-03-13 Method for preventing and treating peripheral neurophathy by administering selegiline

Publications (1)

Publication Number Publication Date
HK1018204A1 true HK1018204A1 (en) 1999-12-17

Family

ID=21760384

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103182A HK1018204A1 (en) 1996-03-15 1999-07-23 A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy

Country Status (8)

Country Link
US (4) US6239181B1 (zh)
EP (1) EP0906090A1 (zh)
JP (1) JP3258027B2 (zh)
CN (1) CN1116870C (zh)
AU (1) AU709323B2 (zh)
CA (1) CA2244253C (zh)
HK (1) HK1018204A1 (zh)
WO (1) WO1997033572A1 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975366A1 (en) * 1997-03-13 2000-02-02 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Cytoprotective agents comprising monoamine oxidase inhibitors
US6417160B1 (en) 1997-10-14 2002-07-09 Nadine A. Tatton Methods for increasing schwann cell survival
US6809120B1 (en) * 1998-01-13 2004-10-26 University Of Saskatchewan Technologies Inc. Composition containing propargylamine for enhancing cancer therapy
ES2178405T3 (es) 1998-03-16 2002-12-16 Somerset Pharmaceuticals Inc Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
ATE499103T1 (de) * 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
PT1441708E (pt) 2001-11-05 2009-06-18 Krele Pharmaceuticals Llc Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo
WO2003075906A1 (en) * 2002-03-04 2003-09-18 Somerset Pharmaceuticals, Inc. Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
US6660736B2 (en) 2002-03-27 2003-12-09 Hoffmann-La Roche Inc. Phthalimido derivatives and a process for their preparation
KR100681585B1 (ko) 2002-04-26 2007-02-09 에프. 호프만-라 로슈 아게 아이소퀴놀린 유도체
DK1511718T3 (da) 2002-05-29 2009-06-22 Hoffmann La Roche N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer
US6900354B2 (en) 2002-07-15 2005-05-31 Hoffman-La Roche Inc. 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
US6846832B2 (en) 2002-08-07 2005-01-25 Hoffman-La Roche Inc. 2,3-dihydro-isoindol-1-one derivatives
TWI286132B (en) 2002-09-20 2007-09-01 Hoffmann La Roche 4-pyrrolidino-phenyl-benzyl ether derivatives
CN100418954C (zh) 2002-12-13 2008-09-17 弗·哈夫曼-拉罗切有限公司 3h-喹唑啉-4-酮衍生物
US7148362B2 (en) 2003-09-18 2006-12-12 Hoffmann-La Roche Inc. Process for the preparation of enantiopure pyrrolidin-2-one derivatives
CA2543287A1 (en) 2003-10-23 2005-05-06 F.Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
ES2319213T3 (es) 2004-06-23 2009-05-05 F. Hoffmann-La Roche Ag Inhibidores de mao-b.
AU2005268894B2 (en) 2004-08-02 2010-12-16 F. Hoffmann-La Roche Ag Benzyloxy derivatives as MAOB inhibitors
US7501528B2 (en) 2005-03-15 2009-03-10 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
JP4796620B2 (ja) 2005-03-15 2011-10-19 エフ．ホフマン−ラ ロシュ アーゲー エナンチオマー的に純粋な４−ピロリジノフェニルベンジルエーテル誘導体の製造方法
JP2010511028A (ja) * 2006-11-30 2010-04-08 ハンター−フレミング・リミテッド プロスタグランジン／シクロオキシゲナーゼの代謝経路の調節
EP2235239A4 (en) * 2007-12-27 2011-05-11 Helicon Therapeutics Inc DEVELOPMENT OF NEURITIES AS A DOSAGE FOR MEMORY ENHANCING COMPOUNDS
US8420088B2 (en) 2008-01-28 2013-04-16 Novartis Ag Methods and compositions using FGF23 fusion polypeptides
TW200936156A (en) 2008-01-28 2009-09-01 Novartis Ag Methods and compositions using Klotho-FGF fusion polypeptides
WO2010009572A1 (zh) * 2008-07-23 2010-01-28 国防教育研究基金会 含异烟碱酰胺（isoniazid, inh）低副作用的新复方
AU2011314358B2 (en) 2010-09-01 2016-07-07 Tonix Pharmaceuticals, Inc. Treatment for cocaine addiction
WO2013027191A1 (en) 2011-08-25 2013-02-28 Novartis Ag Methods and compositions using fgf23 fusion polypeptides
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
KR20170084332A (ko) 2014-12-04 2017-07-19 노파르티스 아게 Klotho 변이체 폴리펩티드를 사용하는 방법 및 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868218A (en) * 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
EP1413299A3 (en) * 1991-04-04 2004-05-06 The University Of Toronto Innovations Foundation Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function
US5444095A (en) 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells

Also Published As

Publication number Publication date
JP3258027B2 (ja) 2002-02-18
US6500868B2 (en) 2002-12-31
JPH11507951A (ja) 1999-07-13
WO1997033572A1 (en) 1997-09-18
EP0906090A1 (en) 1999-04-07
AU2339797A (en) 1997-10-01
CN1213300A (zh) 1999-04-07
US6538036B2 (en) 2003-03-25
US20010023260A1 (en) 2001-09-20
CN1116870C (zh) 2003-08-06
CA2244253C (en) 2002-11-12
US20030181529A1 (en) 2003-09-25
US6743824B2 (en) 2004-06-01
AU709323B2 (en) 1999-08-26
CA2244253A1 (en) 1997-09-18
US20030013771A1 (en) 2003-01-16
US6239181B1 (en) 2001-05-29

Similar Documents

Publication Publication Date Title
HK1018204A1 (en) A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy
HRP960365B1 (en) New medicaments and the use thereof
GB2276639B (en) Solutions for wood treatment and their preparation
GB9416798D0 (en) Delivery valve
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
HUP0001063A3 (en) Use of green porphyrins in the manufacture of a medicament treating atherosclerosis
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
HK1001286A1 (en) Benzopyrans and their use as therapeutic agents.
IL112602A0 (en) N,n-dimethyl-1-Ú1-(4-chlorophenyl)cyclobutyl¾-3-methylbutylamine in the treatment of epilepsy
ZA935575B (en) Therapeutic agent and its use.
GB2319729B (en) A film for topical use in the treatment of wounds
EP0369035A4 (en) Agent for treating pancreatitis or the like
HU9402578D0 (en) Medicament for treating or preventing cerebrovascular diseases
GB2294646B (en) Material treatment
EP0698361A3 (de) Dekubitusbett
GB9415900D0 (en) Novel compounds and treatment
ZA984585B (en) Use of a pharmaceutical composition in the treatment of taumatic arthritis in horses
CA2248753A1 (en) Use of olanzapine for treating excessive aggression
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
GB2292978B (en) Delivery valves
GB9523066D0 (en) Compounds and their therapeutic use
GB9719076D0 (en) A material for producing a medical dressing and a medical dressing produced using the material
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
GB9515166D0 (en) Footwear and the manufacture thereof
GB9424852D0 (en) Fungicidal treatment

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100313